Related Experiment Video
Updated: Jun 10, 2026

Detection of Human Leukocyte Antigen Biomarkers in Breast Cancer Utilizing Label-free Biosensor Technology
Published on: March 24, 2015
Nanoheterojunction-Based Self-Powered Biosensor Integrated with Smartphones for Early Cancer Detection
Jing Xu1, Hanxiao Chen1, Yifang Tao1
1Department·of Urology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
None:
Early diagnosis of cancer is critical for improving patient survival rates. As biomarkers closely associated with tumorigenesis, microRNAs (miRNAs) remain challenging to detect with sufficient sensitivity, simplicity, and portability. This study presents a self-powered, dual-readout electrothermal biosensing chip that integrates an enzyme-free catalytic hairpin assembly (CHA) amplification strategy with hierarchical SnO2@MoS2 hollow spheres for highly sensitive and specific detection of microRNA-126 (miRNA-126). The target miRNA concentration is directly quantified via electrochemical signals, while a thermal transduction mechanism converts electrochemically generated intermediates into the photothermal agent Oxidized 3,3',5,5'-tetramethylbenzidine (oxTMB). Both electrochemical and thermal signals are visualized in real time through a smartphone interface, enhancing detection reliability and interpretability. Compared with conventional single-mode electrochemical methods, this platform reduces cost and operational complexity through enzyme-free amplification, while dual-signal cross-validation improves accuracy. The energy-autonomous design eliminates the need for an external power supply, enabling portable, on-site rapid testing. Experimental results demonstrate a picomolar detection limit for miRNA-126 and excellent performance in serum samples. Overall, this study provides a promising strategy for sensitive and specific early cancer screening and point-of-care diagnostics.

